SMN2 and proximal spinal muscular atrophy: For example, agents aimed at augmentation of SMN2 expression, such as histone deacetylase (HDAC) inhibitor treatment, have been demonstrated to ameliorate motor deficits and increase lifespan in Taiwanese SMA model mice [28, 54, 55].